Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- PMS Study to Verify Usefulness of Taiho's TS-1
July 1, 2002
- Sales of Radicut Exceed MPC's Expectation
July 1, 2002
- New GCP GL Fully Applied in Most Clinical Trials At Present
July 1, 2002
- WEBSITE NEWS
June 24, 2002
- Sugi Pharmacy Installs Clean Benches in Drugstores
June 24, 2002
- BUSINESS NEWS IN BRIEF
June 24, 2002
- Terumo: Glucose Meter with Voice Guide Function
June 24, 2002
- Kusuri Provervs Reveal Japanese Spirit (11)
June 24, 2002
- J&J Sponsors Seminar on Shunt Intervention
June 24, 2002
- 29 Products Including Zomig RM Added to NHI List
June 24, 2002
- Medtronic, Baxter Present Reports on Products Using Swine Heart Valves
June 24, 2002
- Establishment of Fast-track System Requested Again by FPMAJ: PAL Hearings
June 24, 2002
- MEDICAL DEVICE NEWS IN BRIEF
June 24, 2002
- Iressa Recommended for Approval by CDFS Panel
June 24, 2002
- BD: New M. tuberculosis Susceptibility Testing Reagent
June 24, 2002
- Science and Technology White Paper Stresses Importance of Innovation
June 24, 2002
- MBL Gets License from Oncotherapy Science
June 24, 2002
- Precautions against Stevens-Johnson Syndrome Issued Again
June 24, 2002
- DIAGNOSTIC NEWS IN BRIEF
June 24, 2002
- 46 Active Ingredients Listed for Quality Reevaluation
June 24, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…